Patient info Open main menu

Tranexamic Acid Rivopharm 500 mg film-coated tablets – patient leaflet, side effects, dosage

Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
500 mg
Contains active substance:
Similar medicines:

Patient leaflet - Tranexamic Acid Rivopharm 500 mg film-coated tablets

1. WHAT TRANEXAMIC ACID RIVOPHARM TABLETS ARE AND WHAT THEY ARE USED FOR

Tranexamic Acid belongs to a group of medicines called anti-fibrinolytic drugs. These are used to stop or reduce unwanted bleeding. When you bleed your body forms clots to stop the bleeding. In some people these break down causing too much bleeding. Tranexamic Acid stops these clots dissolving and so reduces unwanted bleeding.

Tranexamic Acid is used to prevent or reduce bleeding for a short period of time in many different conditions. You may have been prescribed it for one of the following:

  • Following prostate surgery (post-prostatectomy)
  • Following bladder surgery
  • Heavy periods (menorrhagia)
  • Nose bleeds (epistaxis)
  • Cervical surgery (conisation of the cervix)
  • Bleeding inside the eye (traumatic hyphaema)
  • Tooth removal (dental extraction) in haemophiliacs (people who bleed more easily than normal). You will know if this refers to you
  • A hereditary disease called angioneurotic oedema (HANO). A doctor will have told you if you have this

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TRANEXAMIC ACID RIVOPHARM TABLETS

Do not take Tranexamic Acid Rivopharm Tablets:

  • if you are allergic to tranexamic acid or any of the other ingredients of this medicine (listed in section 6)
  • if you have serious problems with your kidneys (kidney failure)
  • if you have or have ever had a blood clot in your blood vessels (called a `thrombosis’)
  • if you have a history of blood clots in your blood vessels (called a `thrombosis’)
  • if you are at a risk of excessive bleeding as a result of a bleeding disorder called consumption coagulopathyif you have a history of fit

If any of the above applies to you, talk to your doctor or pharmacist.

Warning and precautions

Talk to your doctor before taking Tranexamic Acid Rivopharm Tablets:

  • if you have blood in your urine. This may increase the risk of blockage of the urinary tract.
  • if you have ever had any uncontrollable bleeding
  • if you have disseminated intravascular coagulation (DIC), a disease where your blood starts to clot throughout your body
  • if you have been taking medicine to treat a hereditary disease called angioneurotic oedema (HANO) every day for a long time. If so, you may need to have regular eye tests and blood tests to check your liver is working properly
  • if you are a woman with irregular periods
  • if you have a history of blood clots in your blood vessels (called a `thrombosis’)
  • if anyone in your family has suffered from blood clots in their blood vessels
  • if you have kidney disease.
  • if you takeoral contraceptives. This may increase the risk of blood clots forming.

Other medicines and Tranexamic Acid Rivopharm Tablets

  • Tell your doctor if you are taking, have recently taken or might take any other medicines, in particular the followingFibrinolytic drugs (used to help dissolve blood clots), such as streptokinase. This is because Tranexamic Acid will stop these drugs working

Pregnancy and breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Tranexamic acid film-coated tablets has no or little effect on the ability to drive and use machines. Visual disturbances may occur after taking tranexamic acid.

Tranexamic acid contains sodium

This medicine contains less than 1 mmol sodium (23mg) per tablet, that is to say essentially ‘sodium-free’.

3. HOW TO TAKE TRANEXAMIC ACID RIVOPHARM TABLETS

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Important:

Your doctor will choose the dose that is right for you. Your dose will be shown clearly on the label that your pharmacist puts on your medicine. If it does not, or you are not sure, ask your doctor or pharmacist.

Remember: Your medicine should always be taken with a glass of water. The tablets should be swallowed whole. Do not crush or chew them.

Adults and the elderly:

  • The usual dose is 2 or 3 tablets taken two to three times daily
  • The exact dose you take will depend on why you have been prescribed these tablets
  • Follow your doctor’s instructions about how many tablets to take, when to take them and for how long.

Use in children and adolescents:

  • Your doctor will tell you exactly how much medicine you should give your child. They will work out the dose according to how much your child weighs.

Patients with kidney problems:

  • Your doctor will tell you how much to take. The dose you take may be lower than the usual adult dose.

If you take more Tranexamic Acid Rivopharm Tablets than you should

If you accidentally take too much of your medicine, immediately tell your doctor or go to the nearest hospital casualty department.

Taking too many Tranexamic Acid Rivopharm Tablets may cause diarrhoea or make you feel sick, be sick or be dizzy or light-headed upon standing.

If you forget to take Tranexamic Acid Rivopharm Tablets

Do not take a double dose to make up for a forgotten dose. Simply take the next dose as planned. If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking this medicine and tell your doctor immediately to the hospital if you experience any of the following symptoms:

Rare ( may affect up to 1 in 1,000 people):

  • problems with your eyesight, especially your colour vision;
  • a blood clot in your eye. This may cause bleeding in the eye, or a loss of vision;
  • itchy, red or swollen skin

Very rare (may affect up to 1 in 10,000 people):

  • Feeling sick
  • Being sick
  • Diarrhoea
  • A blood clot in your blood vessels (called a ‘thrombosis’)

Stop taking this medicine and go immediately to hospital if you experience any of the following symptoms:

Rare (may affect up to 1 in 1,000 people):

  • a blood clot in your leg or lungs, the symptoms of which may include:
  • pain, swelling or redness in your leg
  • difficulty breathing or shortness of breath
  • chest pain, which may get worse while breathing

Very rare (may affect up to 1 in 10,000 people)

  • Allergic reaction, the symptoms of which may include:
  • swelling of your throat and tongue
  • difficulty breathing or shortness of breath
  • difficulty swallowing, tightness in your throat or a hoarse voice
  • wheezing, coughing or noisy breathing
  • a rash that is swollen, raised or itchy

Frequency not known (cannot be estimate from the available data)

  • Convulsions, particularly in cases of misuse
  • Sudden onset kidney problems due to death of the tissue in the outer part of the kidney (acute renal cortical necrosis)
  • An allergic reaction that usually recurs at the same site(s) on re-exposure to the medication and may include round or oval patches of redness and swelling of the skin, blistering, and itching (fixed drug eruption). Darkening of the skin in affected areas, which might persist after healing, may also occur.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also reportside effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. HOW TO STORE TRANEXAMIC ACID RIVOPHARM TABLETS

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.

Do not store above 30 °C. Store in the original package.

Do not throw away any medicines via wastewater or house hold waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. CONTENT OF PACK AND OTHER INFORMATION

What Tranexamic Acid Rivopharm Tablets contains:

  • The active substance is tranexamic acid. Each film-coated tablet contains 500 mg tranexamic acid.
  • The other ingredients are:

    Tablet core: Cellulose microcrystalline, povidone (K 90), croscarmellose sodium, silica colloidal anhydrous, talc, magnesium stearate;

    Film coating: methacrylate polymers, titanium dioxide (E171), talc, magnesium stearate, macrogol (8000).

What Tranexamic Acid Tablets looks like and contents of the pack

Tranexamic Acid Rivopharm tablets are white to off white, capsule shaped, biconvex film-coated tablets. They are marked with TXA 500 with a break line.

The tablets come in blister packs containing 60 tablets.

Marketing authorisation holder and Manufacturer

Rivopharm UK Ltd

100 Bishopsgate

London

EC2N 4AG

United Kingdom

This leaflet was last approved in February 2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 33155/0010

MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Tranexamic Acid Rivopharm 500 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Tranexamic acid
Strength 500 mg
Pharmaceutical form Oral tablet
Tranexamic Acid Rivopharm 500 mg film coated tablets are white to off white, capsule shaped, biconvex film-coated tablets. They are marked with TXA 500 with a break line.
How is it taken Oral
Excipients Tablet core: Cellulose microcrystalline, povidone (K 90), croscarmellose sodium, silica colloidal anhydrous, talc, magnesium stearate;, Film coating: methacrylate polymers, titanium dioxide (E171), talc, magnesium stearate, macrogol (8000).
Pack sizes 60 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months.
Storage Do not store above 30°C. Store in the original package.
Drug group (ATC) Antihemorrhagics, antifibrinolytics
  1. B Blood and blood forming organ drugs
    1. B02 Antihemorrhagics
      1. B02A Antifibrinolytics
        1. B02AA Antifibrinolytic amino acids
          1. B02AA02 tranexamic acid
Marketing authorisation PL 33155/0010 (first authorised 24 October 2024)
Marketing authorisation holder Rivopharm UK Ltd
Codes GTIN 5060388650186 · BNF 02110000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.